EU_Logo_100W_100H

IMI_Logo_294W_90H

Dissemination Activities

The iABC project will advance the development of inhaled treatments for patients with Cystic Fibrosis and Bronchiectasis. Below is a list of dissemintation activities relating to the iABC project.

Nature of Communication

Title

Responsible Participant (and presenter when relevant)

Date/location when relevant.

Target audience

Oral

presentation

at the

congress of

the European

Respiratory

Society (ERS),

Amsterdam

 

Inhaled antibiotic

therapies in

Bronchiectasis

 

Prof Stuart Elborn (Belfast, UK)

September 28,

2015

 

Scientific

community

 

ERS

symposium

2015 in

Amsterdam

 

 

Dr James Chalmers (Dundee, UK)

September 2015

Scientific

community

 

Study

information

posted on

Clinical

trials.gov

 

NCT02712983

Gerhild Angyalosi (Novartis, CH)

February

5, 2016

 

Scientific &

medical

community

 

Research

Priorities in

BE

 

Aliberti S,

Masefield S, Polverino E, De Soyza A, Loebinger M, Menendez R, Ringshausen FC,

Vendrell M, Powell P, Chalmers JD.

Research priorities

in bronchiectasis - a consensus statement

of the EMBARC

Clinical Research

Collaboration.

European

Respiratory Journal in press

http://www.ncbi.nlm.nih.gov/pub

med/27288031

A publication focussed on future

directions and priorities for

bronchiectasis

 

Sep 2016

Scientific

community

 

1st World

Bronchiectasis Conference,

Hannover,

Germany

 

Project presentation

Dr James Chalmers

July 2016

Medical

community,

patients,

policymakers

 

Poster presentation

Dose finding study to find the efficacy, safety and tolerability of tobramycin inhalation powder in patients with non-cystic fibrosis bronchiectasis and pulmonary P.aeruginosa infection (iBEST-1)

Gerhild Angyalosi

7th July 2017/ World BE conference, Milan

Scientific community, patients organisations